Asset Details
Do you wish to reserve the book?
Emerging Opportunities for Site-Specific Molecular and Cellular Interventions in Autoimmune Hepatitis
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Emerging Opportunities for Site-Specific Molecular and Cellular Interventions in Autoimmune Hepatitis
Do you wish to request the book?
Emerging Opportunities for Site-Specific Molecular and Cellular Interventions in Autoimmune Hepatitis
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Emerging Opportunities for Site-Specific Molecular and Cellular Interventions in Autoimmune Hepatitis
2010
Overview
Current corticosteroid-based treatments of autoimmune hepatitis frequently have incomplete or unsatisfactory outcomes, side effects, and excessive immune suppression. The goal of this review is to describe the advances in developing animal models of autoimmune hepatitis and in treating diverse immune-mediated diseases that make pursuit of site-specific molecular and cellular inventions in autoimmune hepatitis feasible. Prime source and review articles in English were selected by a Medline search through October 2009. A murine model infected with an adenovirus expressing human CYP2D6 is a resource for evaluating new therapies because of its histological and serological features, persistence, and progressive hepatic fibrosis. Synthetic analog peptides that block autoantigen expression, a dimeric recombinant human fusion protein of cytotoxic T lymphocyte antigen-4, monoclonal antibodies against tumor necrosis factor-alpha, recombinant interleukin 10, tolerization techniques for disease-triggering autoantigens, T regulatory cell transfer, vaccination against antigen-specific cytotoxic CD8+ T cells, and gene silencing methods using small inhibitory RNAs are feasible interventions to explore. Treatments directed at dampening immunocyte activation with soluble cytotoxic T lymphocyte antigen-4, inhibiting immunocyte differentiation with recombinant interleukin 10, and improving immunosuppressive activity with regulatory T cell modulation have the most immediate promise. Progress in the development of an animal model of autoimmune hepatitis and experiences in other immune-mediated diseases justify the evaluation of site-specific molecular and cellular interventions in this disease.
Publisher
Boston : Springer US,Springer US,Springer,Springer Nature B.V
Subject
/ Analysis
/ Animals
/ B cells
/ Biological and medical sciences
/ Fundamental and applied biological sciences. Psychology
/ Gastroenterology. Liver. Pancreas. Abdomen
/ Hepatitis, Autoimmune - drug therapy
/ Hepatitis, Autoimmune - immunology
/ Humans
/ Immunosuppressive Agents - therapeutic use
/ Liver. Biliary tract. Portal circulation. Exocrine pancreas
/ Medicine
/ Oncology
/ Review
/ Signal Transduction - immunology
/ T cells
/ Vertebrates: anatomy and physiology, studies on body, several organs or systems
We currently cannot retrieve any items related to this title. Kindly check back at a later time.